mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.004 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
0.005 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.006 |